These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37359940)

  • 21. Long-term results of laparoscopic cytoreductive surgery and HIPEC for the curative treatment of low-grade pseudomyxoma peritonei and multicystic mesothelioma.
    Mercier F; Jeremie G; Alyami M; Delphine V; Vahan K; Pascal R; Sylvie I; Guillaume P; Olivier G
    Surg Endosc; 2020 Nov; 34(11):4916-4923. PubMed ID: 31792692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laparoscopic cytoreductive surgery and HIPEC: a comparative matched analysis.
    Rodríguez-Ortiz L; Arjona-Sánchez A; Ibañez-Rubio M; Sánchez-Hidalgo J; Casado-Adam A; Rufián-Peña S; Briceño-Delgado J
    Surg Endosc; 2021 Apr; 35(4):1778-1785. PubMed ID: 32328823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes in Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).
    Zambrano-Vera K; Sardi A; Munoz-Zuluaga C; Studeman K; Nieroda C; Sittig M; King MC; Sipok A; Gushchin V
    Ann Surg Oncol; 2020 Jan; 27(1):179-187. PubMed ID: 31646450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laparoscopic HIPEC for Peritoneal Carcinomatosis from Gastric Cancer - Technique and Early Outcomes of Our First Cases.
    Bălescu I; Godoroja D; Gongu M; Tomulescu V; Copăescu C
    Chirurgia (Bucur); 2017; 112(6):714-725. PubMed ID: 29288614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytoreductive Surgery with Hyperthermic Intrathoracic Chemotherapy for Patients with Intrapleural Dissemination of Peritoneal Surface Malignancies.
    Nikiforchin A; Gushchin V; King MC; Baron E; Lopez-Ramirez F; Sardi A
    Ann Surg Oncol; 2021 Dec; 28(13):9126-9135. PubMed ID: 34263367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Learning curve for minimal invasive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) procedures.
    Durán-Martínez M; Gómez-Dueñas G; Rodriguez-Ortíz L; Sanchez-Hidalgo JM; Suárez AG; Casado-Adam Á; Rufián-Peña S; Andujar BR; Valenzuela-Molina F; Vázquez-Borrego MC; Romero-Ruiz A; Briceño-Delgado J; Arjona-Sánchez Á
    Langenbecks Arch Surg; 2023 Apr; 408(1):146. PubMed ID: 37046100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: outcomes from a single tertiary institution.
    Tabrizian P; Shrager B; Jibara G; Yang MJ; Romanoff A; Hiotis S; Sarpel U; Labow DM
    J Gastrointest Surg; 2014 May; 18(5):1024-31. PubMed ID: 24577736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laparoscopic cytoreductive surgery and HIPEC in LAMN with small volume of peritoneal disease: a valuable option of treatment for good patient-related experience measures (PREMs).
    Cusumano C; Carrere S; Bouillin A; Nougaret S; Khellaf L; Quénet F; Sgarbura O
    Surg Endosc; 2022 Jul; 36(7):4757-4763. PubMed ID: 34845545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for perforated low-grade appendiceal mucinous neoplasms.
    Abudeeb H; Selvasekar CR; O'Dwyer ST; Chakrabarty B; Malcolmson L; Renehan AG; Wilson MS; Aziz O
    Surg Endosc; 2020 Dec; 34(12):5516-5521. PubMed ID: 31993814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of cytoreductive surgery and HIPEC for peritoneal surface malignancies: analysis of 384 consecutive cases.
    Narasimhan V; Das A; Warrier S; Lynch C; McCormick J; Tie J; Michael M; Ramsay R; Heriot A
    Langenbecks Arch Surg; 2019 Aug; 404(5):527-539. PubMed ID: 31377856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes from cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal epithelial neoplasms.
    Narasimhan V; Pham T; Warrier S; Craig Lynch A; Michael M; Tie J; Ramsay R; Heriot A
    ANZ J Surg; 2019 Sep; 89(9):1035-1040. PubMed ID: 30685879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic Laparoscopy in Patients With Peritoneal Carcinomatosis Is Safe and Does Not Delay Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy.
    Hanna DN; Ghani MO; Hermina A; Mina A; Bailey CE; Idrees K; Magge D
    Am Surg; 2022 Apr; 88(4):698-703. PubMed ID: 34732056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases - The Hong Kong experience and literature review.
    Chow FC; Yip J; Foo DC; Wei R; Choi HK; Ng KK; Lo OS
    Asian J Surg; 2021 Jan; 44(1):221-228. PubMed ID: 32605790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the outcomes of cytoreductive surgery versus surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: a propensity score matching analysis.
    Li Z; Redondo Ntutumu JD; Huang S; Cai Z; Han S; Balde AI; Luo Z; Fang S
    Surg Endosc; 2021 Jun; 35(6):2789-2796. PubMed ID: 32632486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized center.
    Yu HH; Yonemura Y; Hsieh MC; Mizumoto A; Wakama S; Lu CY
    Cancer Manag Res; 2017; 9():513-523. PubMed ID: 29089784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) vs CRS alone for treatment of endometrial cancer with peritoneal metastases: a multi-institutional study from PSOGI and BIG RENAPE groups.
    Gomes David M; Bakrin N; Salleron J; Kaminsky MC; Bereder JM; Tuech JJ; Lehmann K; Mehta S; Glehen O; Marchal F
    BMC Surg; 2022 Jan; 22(1):1. PubMed ID: 34996419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients.
    Ji ZH; Yu Y; Liu G; Zhang YB; An SL; Li B; Li XB; Yan GJ; Li Y
    Eur J Surg Oncol; 2021 Jun; 47(6):1411-1419. PubMed ID: 33293213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: The University of Arizona early experience.
    Konstantinidis IT; Young C; Tsikitis VL; Lee E; Jie T; Ong ES
    World J Gastrointest Surg; 2012 Jun; 4(6):135-40. PubMed ID: 22816027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initial Experience Using Laparoscopic HIPEC for Gastric Cancer with Peritoneal Metastasis: Safety and Outcomes.
    Read MD; Drake J; Hashemipour G; Powers BD; Mehta R; Sinnamon A; Pimiento JM; Dineen SP
    Ann Surg Oncol; 2024 Jun; 31(6):3750-3757. PubMed ID: 38430428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignant tumors in children: Initial experience in a single institution.
    Zhu Z; Chang X; Wang J; Yang S; Qin H; Yang W; Cheng H; Meng D; Wang H
    Front Surg; 2022; 9():1078039. PubMed ID: 36713659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.